Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Reversal of multidrug resistance in human colon carcinoma cells

Reversal of multidrug resistance in human colon carcinoma cells

US Patent 6878737 · Granted Apr 12, 2005

Estimated economic value: $345,421,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antineoplastic combinations with mTOR inhibitor, trastuzumab and/or HKI-2722020
Method for treating gefitinib resistant cancer2020
Method for treating gefitinib resistant cancer2020
Antibacterial lipopeptides and methods for their preparation and use2018
Spliceostatin analogs and methods for their preparation2017
Spliceostatin analogs and methods for their preparation2016
LNA antisense oligonucleotides for the modulation of Myc expression2016
Spliceostatin analogs and methods for their preparation2015
Substituted pyrimidine kinase inhibitors2011
Protein tyrosine kinase enzyme inhibitors2011
Substantially pure glycopeptide antibiotics AC-98-1 ; AC-98-2; AC-98-3; AC-98-4 2010
Protein tyrosine kinase enzyme inhibitors2008